Call for Abstracts

2026 Poster and Short Talk Presentation Guidelines2026 Abstract Submission GuidelinesAbstract Book

Abstract submission will close on March 6, 2026.

Please note that participation in the conference is mandatory for all abstract presenters.

To submit an abstract, presenters must first register for the CIMT Annual Meeting. Once registered, you will receive a unique conference registration number. This number is required for the online abstract submission. Abstract submissions cannot be completed without prior conference registration and the associated registration number.

Abstracts will undergo a blind peer-review process, with the top 10% chosen for short talk presentations.
________________________________________________________________________________

Abstracts will be rejected if they fall outside the scope of the meeting (e.g., not related to cancer immunology or immunotherapy), if they are purely commercial in nature, or if they clearly violate scientific standards.
________________________________________________________________________________

ABSTRACT SUBMISSION CATEGORIES

Improving Immunity:

This session is for everyone whose research is focused on inspiring, new strategies to enhance anti-tumor immune responses.
New Targets & Biomarkers:
Present your poster in this session if you report on an exciting new target structure, or if you work on the identification and characterization of biomarkers in the pre-clinical and clinical setting.
Cellular Therapies:

From T-cell receptor therapy to chimeric antigen receptors – this session is all about cellular therapies, and not only restricted to T cells.
Tumor Biology:
Choose this session if your aim is to unravel the complexity of the tumor microenvironment and to improve our understanding of the interaction between tumor and immune cells.
Novel Tools & Technologies:
Have you developed a new tool, technology, or novel computational approaches, be it related to multiplexed imaging or single-cell transcriptomics? In this session, you can present the technology as well as the insights it enables.


PRESENTING YOUR WORK

All accepted abstracts are presented as posters. Through a blind evaluation by our abstract review committee members, highly-rated abstract submissions are additionally selected for short talk presentation.

Poster Awards for early-career researchers are determined by a dedicated prize committee who actively engage with the poster exhibits. Prize winners are honored during the conference, highlighting their research on an international stage.

Please download the Poster and Short Talk Presentation Guidelines above for additional information

Every year CIMT honors outstanding poster presentations of junior researchers with the CIMT Poster Awards.

CIMT 2026 Poster Awards

Five early-career researchers were chosen by the CIMT poster jury members to receive the 2026 CIMT Poster Awards supported by Immatics in six categories:

Improving Immunity
Chiara Maria Cattaneo
IRCC Humanitas Research Hospital, Italy
New Targets & Biomarkers
Marta Maccari
Veneto Institute of Oncology & University of Padova, Italy
Tumor Biology
Giovanna Giacca
San Raffaele Telethon Institute for Gene and Cell Therapy, Italy
Cellular Therapy
Bianca Broske
University Hospital Bonn, Germany
Novel Tools & Technologies
Celina Honhoff
Princess Máxima Center for Pediatric Oncology, The Netherlands
2020
2019

Travel Awards

Travel Awards

Please note that travel awards will not be offered for the 2026 conference.

Jesus Junco Barranco (Cuba)
Monica Romero (Cuba)
Raanan Greenman (Israel)
Alper Kursune (Turkey)
Didem Özkazanc (Turkey)
Fortis Sotirios (Greece)
Annunziata Nigro (Italy)
Barbara Carreira (Portugal)
Liane Moura (Portugal)
Rita Acurcio (Portugal)
Quentin Lecocq (Belgium)
Vania Lo Presti (Netherlands)
Su Yin (Esther) Lim (Australia)
Travel awards application informationWorld Bank country list

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development